Iron accumulation in the basal ganglia in Huntington's disease: Cross-sectional data from the IMAGE-HD study
Version 2 2024-06-05, 06:47Version 2 2024-06-05, 06:47
Version 1 2020-01-30, 13:51Version 1 2020-01-30, 13:51
journal contribution
posted on 2024-06-05, 06:47 authored by JF Domínguez D, ACL Ng, G Poudel, JC Stout, A Churchyard, P Chua, GF Egan, N Georgiou-Karistianis© 2016, BMJ Publishing Group. All rights reserved. Objectives: To measure iron accumulation in the basal ganglia in Huntington's disease (HD) using quantitative susceptibility mapping (QSM), and to ascertain its relevance in terms of clinical and disease severity. Methods: In this cross-sectional investigation, T2∗ weighted imaging was undertaken on 31 premanifest HD, 32 symptomatic HD and 30 control participants as part of the observational IMAGE-HD study. Group differences in iron accumulation were ascertained with QSM. Associations between susceptibility values and disease severity were also investigated. Results: Compared with controls, both premanifest and symptomatic HD groups showed significantly greater iron content in pallidum, putamen and caudate. Additionally, iron accumulation in both putamen and caudate was significantly associated with disease severity. Conclusions: These findings provide the first evidence that QSM is sensitive to iron deposition in subcortical target areas across premanifest and symptomatic stages of HD. Such findings could open up new avenues for biomarker development and therapeutic intervention.
History
Journal
Journal of Neurology, Neurosurgery and PsychiatryVolume
87Pagination
545-549Location
EnglandPublisher DOI
ISSN
0022-3050eISSN
1468-330XLanguage
EnglishPublication classification
C1 Refereed article in a scholarly journalIssue
5Publisher
BMJ PUBLISHING GROUPUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC